Saving changes...



Indications and Evidence for Proton Beam Therapy

Indications and Evidence for Proton Beam Therapy

Indications and Evidence for Proton Beam Therapy

Roger Taylor
Roger Taylor
on behalf of Health Education England

$30.00 $ 30.00 $ 30.00

$ 30.00 30.00 30.00
30.00 $ 30.00 30.00 30.00
Normal Price: $30.00 $30.00


Launch date: 14 Jun 2018
Expiry Date:

Last updated: 14 Jun 2018

Reference: 189877

TIming: null

Maximum Attendees:

Places Left: 0

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

You have null days left.


This session aims to present the clinical rationale for proton beam therapy (PBT), and the evidence for treatment of different types of cancer.


By the end of this session you will be able to:
• State the main rationale for using PBT in children and adults
• Explain, for selected clinical indications, the advantage that would be anticipated from PBT, for example, better local control and/or reduced late effects to specific normal organs, to a level to be able to discuss indications with patients
• Recognise the importance of clinical trials and late effects programs in contributing to the evidence base for PBT
• Recognise and understand the principles which underpin potential future new indications
Roger Taylor

Author Information Play Video Bio

Roger Taylor
on behalf of Health Education England

Professor Roger E. Taylor MA, FRCP (Edin), FRCP, FRCR.

Roger trained in medicine at Oxford University and St Bartholomew’s Hospital Medical College. After gaining experience in general medicine, his oncology training took place at the Royal Marsden Hospital, the Royal London Hospital and Edinburgh. From 1987-2006, Roger was Consultant Clinical Oncologist at Cookridge Hospital, Leeds. He has been Professor of Clinical Oncology at Swansea University since 2006. From 2008 until 2017 he was a member of the NHS England Proton Therapy Overseas Clinical Reference Panel.

He was previously a member of the National Radiotherapy Advisory Group (NRAG) Proton Therapy subgroup.

From 2014-2016, he was Vice President, Clinical Oncology, Royal College of Radiologists.

Since December 2016, he has been a Clinical Advisor to the Proton Partners International Rutherford Cancer Centre, South Wales.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Health Education England
  • 0.75 Units -
    Exam Pass Rate: 60

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:


User Reviews (0)

Go Back


Saving changes...